Skip to main content
. 2020 Oct 11;26:e928054-1–e928054-13. doi: 10.12659/MSM.928054

Table 5.

Prognostic analysis on OS in patients with colorectal cancer.

Variables Univariate analysis Multivariate analysis
HR (95%CI) P value HR (95%CI) P value
Incisional SSI 0.598 (0.219–1.635) 0.316
Organ/space SSI 1.222 (0.446–3.351) 0.696
Incisional+organ/space SSI 3.164 (1.862–5.377) <0.001 3.694 (1.346–10.138) 0.011
Sex F Ref.
M 1.081 (0.719–1.626) 0.708
Age ≥60 (year) 2.026 (1.352–3.036) 0.001 1.941 (1.197–3.147) 0.007
Tumor location Colon Ref.
Rectum 0.841 (0.561–1.260) 0.402
Tumor size (cm) <5 Ref.
≥5 1.274 (0.850–1.910) 0.242
Tumor differentiation poor Ref.
high 0.637 (0.367–1.105) 0.109
Lymph node involvement 2.935 (1.921–4.484) <0.001 2.632 (1.625–4.262) <0.001
Depth of tumor T1–T2 Ref. Ref.
T3–T4 3.947 (1.727–9.021) 0.001 2.961 (1.043–8.405) 0.041
Operative approach open Ref. Ref.
Lap 0.537 (0.361–0.800) 0.002 0.681 (0.439–1.057) 0.087
Anastomotic leakage 1.937 (1.133–3.312) 0.016 0.662 (0.213–2.055) 0.475
Adjuvant chemotherapy 0.634 (0.426–0.945) 0.025 0.598 (0.372–0.964) 0.035
Preoperative obstruction 1.184 (0.770–1.821) 0.442
Vascular invasion 1.780 (1.140–2.781) 0.011 0.943 (0.547–1.625) 0.832
Perineural invasion 2.032 (1.326–3.112) 0.001 1.510 (0.936–2.434) 0.091
Blood transfusion 1.306 (0.858–1.987) 0.213
Preoperative CEA (ng/ml) <5 Ref. Ref.
≥5 1.711 (1.147–2.553) 0.009 1.129 (0.716–2.553) 0.603
Preoperative CA125 (ng/ml) <35 Ref. Ref.
≥35 3.106 (1.811–5.326) <0.001 1.892 (1.027–3.485) 0.041
Preoperative CA199 (ng/ml) <37 Ref. Ref.
≥37 2.001 (1.234–3.246) 0.005 1.381 (0.803–2.377) 0.243

SSI –surgical site infection; HR – hazard ratio; CI – confidence interval; F – Female; M – Male; Lap – laparoscopic.